articleTop 1% cited

Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy

British Journal of Ophthalmology · 2007 · Vol. 92(2) · pp. 213–216

J. Fernando Arévalo✉Maurício Maia(Universidade Federal de São Paulo)Harry W. Flynn(University of Miami)Mario Saravia(Hospital Universitario Austral)Robert L. Avery(California Retina Consultants)Lihteh Wu(Instituto de Microcirugía Ocular)Michel Eid Farah(Universidade Federal de São Paulo)Dante J. Pieramici(California Retina Consultants)María H. Berrocal(University of Puerto Rico System)J. García Sánchez

View via DOI Publisher page

Abstract

TRD may occur or progress shortly following administration of intravitreal bevacizumab in patients with severe PDR.

Retinal Diseases and Treatments Retinal and Macular Surgery Retinal Imaging and AnalysisMedicineVitrectomyDiabetic retinopathyOphthalmologyBevacizumabVisual acuityDiabetes mellitusProliferative vitreoretinopathyRetinalSurgery

MeSH terms

BevacizumabAdultAntibodies, MonoclonalDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic RetinopathyFemaleHumansInjectionsMaleMiddle AgedRetinal DetachmentRetrospective StudiesVitrectomyVitreous Body

Citations

405

FWCI

23.87

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema